Frank Cappelleri breaks down the charts in the iShares China Large Cap ETF (FXI).
Is Ozempic to blame for the slowdown in salty snack sales? Here’s the verdict
Investors who worry that rising GLP-1 drug usage has impaired salty snack sales might be pointing the finger at the wrong culprit.
Here’s how Apple might cash in on its latest artificial intelligence features
Wall Street weighs in on whether Apple Intelligence could benefit as a paid tool.
Goldman sees this biotech fighting rare diseases rallying 35%
The bank initiated coverage at a buy rating.
Jefferies says sell the pop in Starbucks stock on new CEO enthusiasm, long turnaround ahead
The Wall Street firm downgraded its rating on the stock and slashed its price target, believing that uncertainty in the near term is high.
A market hedge using options with the S&P 500 up nearly 20% for the year heading into October
Jeff Kilburg breaks down a so-called risk-reversal trade in the S&P 500 SPDR fund.
Morgan Stanley sees this energy stock doubling on a large data center deal like Three Mile Island
Constellation Energy’s contract to help power Microsoft’s data centers demonstrates tech companies are willing to pay a premium for reliable energy.
Here are Tuesday’s biggest analyst calls: Apple, Walmart, Salesforce, Starbucks, Amazon & more
Here are Tuesday’s biggest calls on Wall Street.
Nvidia leads list of 10-bagger stocks the last five years. But be careful
Trivariate Research screened for stocks that have gained ten-fold in a 5-year period over the last quarter century.
Tuesday’s analyst calls: Salesforce to pop more than 20%, Lowe’s gets an upgrade
A software giant and a home improvement retailer were among the stocks being talked about by analysts on Tuesday.